Clinical trials
Phase 2/3 COVID-19 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
267 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 127 |
| 2021 | 83 |
| 2022 | 38 |
| 2023 | 15 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 105 |
| Unknown status | 78 |
| Terminated | 50 |
| Withdrawn | 24 |
| Suspended | 4 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novavax | 5 |
| BioNTech SE | 4 |
| Cairo University | 4 |
| ModernaTX, Inc. | 4 |
| Pfizer | 4 |
| Tanta University | 4 |
| Australian National University | 3 |
| Cambridge University Hospitals NHS Foundation Trust | 3 |
| Hospital Universitario San Ignacio | 3 |
| Sinocelltech Ltd. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 267 |
| Coronavirus Infections | 44 |
| Pneumonia | 12 |
| Virus Diseases | 10 |
| Cytokine Release Syndrome | 9 |
| Severe Acute Respiratory Syndrome | 8 |
| Post-Acute COVID-19 Syndrome | 6 |
| Inflammation | 5 |
| Respiratory Distress Syndrome | 5 |
| Respiratory Insufficiency | 3 |
Trials
Showing 1 to 25 of 267. Each trial links to its page on Pharma Observatory.
167 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.